AHA Scientific Sessions 2026 Abstract · Nov 2, 2026
Mosaic Loss of Chromosome Y and Adverse Cardiovascular Outcomes in Men: A Systematic Review and Meta-Analysis
By Hamzah KA, Shahzaib M, Kurmasha Y et al.
Background: Mosaic loss of chromosome Y (mLOY) is the most common acquired somatic mutation in aging men and has been implicated in age-related diseases. However, its association with cardiovascular outcomes and mortality remains incompletely defined. We performed a systematic review and meta-analysis to evaluate the impact of mLOY on cardiovascular events and mortality. Methods: A systematic search of PubMed, Embase, Scopus, Web of Science, and the Cochrane Library was conducted to identify longitudinal studies evaluating the association between mosaic loss of chromosome Y (mLOY) and clinical outcomes. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using random-effects models in R software. Heterogeneity was assessed using the I ² statistic. Results: Six studies comprising multiple independent cohorts were included. mLOY was associated with a significantly increased risk of all-cause mortality (HR, 1.79 [95% CI, 1.27-2.51]; P=0.0008; I ² =74.8%). mLOY was also associated with a higher risk of major adverse cardiovascular events (HR, 1.04 [95% CI, 1.02-1.06]; P<0.0001) and ischemic heart disease (HR, 1.04 [95% CI, 1.01-1.07]; P=0.004). No significant associations were observed for stroke (HR, 1.02 [95% CI, 0.99-1.05]; P=0.159) or cardiovascular mortality (HR, 0.98 [95% CI, 0.67-1.43]; P=0.916). Conclusions: Mosaic loss of chromosome Y was associated with higher all-cause mortality and an increased risk of ischemic cardiovascular events in men. These findings suggest that mLOY may serve as a biomarker for cardiovascular risk and adverse health outcomes. Further studies are warranted to better understand the underlying mechanisms and potential clinical implications of these associations.